Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–45
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male subjects aged 18 to 45 years (inclusive)
Have a body mass index (BMI) between 19 and 30 kg/m2 and a body weight between 60 and 100 kg.
Be a non-smoker or ex-smoker who has stopped smoking (or using other nicotine products) for \>6 months prior to study start.
Be able to inhale from the Turbuhaler inhaler according to given instructions.
You may not be if
Any clinically significant disease or disorder
Any clinically relevant abnormal findings at screening examination
History of additional risk factors for Torsade de Pointes (eg, heart failure, hypokalaemia, or family history of long QT syndrome).
Any clinically important abnormalities in rhythm, conduction or morphology of resting ECG that may interfere with the interpretation of QTc interval changes.
Clareo Health | To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart
